Publicacións nas que colabora con Jose Manuel Cameselle Teijeiro (7)
2024
-
Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)
Nature Communications
-
Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)
Nature Communications
-
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe
Nature Communications, Vol. 15, Núm. 1
2020
-
GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells
Frontiers in Endocrinology, Vol. 11
2017
-
Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer
Oncogene, Vol. 36, Núm. 5, pp. 652-666
2013
-
Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer
Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 6, pp. 2431-2441
2010
-
Expression of exogenous proteins and short hairpin RNAs in human primary thyrocytes
Analytical Biochemistry, Vol. 400, Núm. 2, pp. 219-228